Pre-clinical or non-clinical studies are required during drug development to evaluate safety in animals (toxicology) and pharmacokinetics and bioavailability (pharmacology) of drugs prior to initiating the clinical development of a drug. These studies must be performed following the Good Laboratory Practices (GLP) regulations, specified by the US FDA or principles and guidelines developed by the Organisation of Economic Co-operation and Development (OECD). Regulations for the GLP, specified in 21 CFR 58, related guidelines, including “questions and answers” documents, a training handbook and training manuals developed by the World Health Organization (WHO) are available to clarify the regulatory expectations with a view to assisting the sponsors of drugs and contract testing laboratories performing toxicology and pharmacology studies in complying with these regulations. Despite these guidance documents and training materials, GLP regulations are one of the most commonly misunderstood regulations for drug development and manufacturing operations with a number of myths about GLPs. This course will explain various elements of GLPs in detail with a view to comply with the regulations and Law as per regulatory requirements and expectations.
Analytical methods are required in evaluating pharmacology of drugs (pharmacokinetics and bioavailability) in animals and humans. The regulatory agencies in the US and Europe have termed these methods as bioanalytical methods. Most of these methods are analytical methods, but these methods when used to detect or quantify the drug in biological fluids or tissues have been referred as bioanalytical methods. Often these methods are confused with biological methods or bioassays commonly used in testing and characterization of biological products or biologics and also used in evaluating functionality (for example, Immunogenicity) of drugs and biologics (functional assays). Regulatory agencies have issued guidelines for validation of bioanalytical methods.
This course will discuss in details the use and validation of bioanalytical methods. For clinical evaluation of drugs, bioanalytical methods and other methods, such as biological assays, immunochemical assays, etc. are used. Clinical trials are conducted under the Good Clinical Practices (GCP) regulations, which mainly deal with conduct of clinical trials and provide not much information or guidelines for the methods used to test clinical samples. Bioanalytical methods used for clinical development are validated by the guidance provided by the regulatory agencies, but there is confusion in validation of biological assays, immunochemical assays, etc. used for clinical samples, as the ICH guidance for method validation (Q2R(1)) deals with methods used to test the product. This course will give an overview on the common practices and ways to validate methods used during clinical development of drugs.
Throughout the course, relevant examples with regard to meeting regulatory expectations will be discussed.
Learning Objectives:
Upon completing this course the participants will understand:
- Good Laboratory Practices (GLP) regulations and their distinction from the current Good Manufacturing Practices (cGMP) regulations
- Myths and Regulatory Expectations about GLP
- Achieving Compliance with GLP regulations
- Challenges with complying with GLP regulations
- Bioanalytical methods and their distinction from Biological methods
- Validation of Bioanalytical Methods
- Validation of Biological, Immunochemical and other Methods used to evaluation clinical samples
….much, much more
Who will Benefit:
- Managers and Scientists involved in Drug Development from Pharmaceutical and Biotech Industry
- Contract Testing Laboratories performing toxicology and pharmacology studies
- Personnel from Laboratories performing Bioanalytical methods
- Personnel from Laboratories testing Clinical samples for determining efficacy of drugs and biologics
- Registration Process: 8:30 AM – 9:00 AM
- Session Start Time: 9:00 AM
- Good Laboratory Practices (GLP) – Introduction
- History of GLP Regulations
- Why these were developed?
- Role in drug development
- High Level Distinction between GLP and Good Manufacturing Practices (GMP)
- Common Myths about GLP
- History of GLP Regulations
- Regulatory Basis for GLPs
- Regulations, US (21 CFR 58), Europe (OECD), UK
- Guidance Documents
- Questions and Answers
- Overview from Training Materials and Manual from WHO
- Basic Elements of GLPs from 21 CFR 58
- Subpart A, General Provisions
- Subpart B, Organization and Personnel
- Subpart C, Facilities
- Subpart D, Equipment
- Subpart E, Testing Facilities Operation
- Subpart F, Test and Control Articles
- Subpart G, Protocol for and Conduct of a Nonclinical Laboratory Study
- Subpart J, Records and Reports
- Subpart K, Disqualification of Testing Facilities
- Organization and Personnel
- 58.29 – Personnel
- 58.31 - Testing facility management
- 58.33 - Study director
- 58.35 - Quality assurance unit
- Facilities
- 58.41 - General
- 58.43 - Animal care facilities
- 58.45 - Animal supply facilities
- 58.47 - Facilities for handling test and control articles
- 58.49 - Laboratory operation areas
- 58.51 - Specimen and data storage facilities
- Equipment
- 58.61 - Equipment design
- 58.63 - Maintenance and calibration of equipment
- Testing Facilities and Operation
- 58.81 - Standard operating procedures
- 58.83 - Reagents and solutions
- 58.90 - Animal care
- Test and Control Articles
- 58.105 - Test and control article characterization
- 58.107 - Test and control article handling
- 58.113 - Mixtures of articles with carriers
- Protocol for and Conduct of a Nonclinical Laboratory Study
- 58.120 - Protocol
- 58.130 - Conduct of a nonclinical laboratory study
- Records and Reports
- 58.185 - Reporting of nonclinical laboratory study results
- 58.190 - Storage and retrieval of records and data
- 58.195 - Retention of records
- Disqualification of Testing Facilities
- 58.200 - Purpose
- 58.202 - Grounds for disqualification
- 58.204 - Notice of and opportunity for hearing on proposed disqualification
- 58.206 - Final order on disqualification
- 58.210 - Actions upon disqualification
- 58.213 - Public disclosure of information regarding disqualification
- 58.215 - Alternative or additional actions to disqualification
- 58.217 - Suspension or termination of a testing facility by a sponsor
- 58.219 - Reinstatement of a disqualified testing facility
- BioAnalytical Methods
- Introduction and their role
- Distinction between Bioanalytical and Biological Methods
- Validation of BioAnalytical Methods
- Regulatory Guidance
- FDA’s Guidance 2013
- EMEA Guidance 2011
- Chromatographic Methods and Ligand Binding Assyas
- Reference Standards and Critical or Key Reagents
- Selectivity
- Accuracy
- Precision and Recovery
- Calibration Curve
- Lower Limit of Quantification (LLOQ)
- Upper Limit of Quantification (ULOQ)
- Sensitivity
- Reproducibility
- Stability
- Validated Method: Use, Data Analysis, and Reporting
- System Suitability
- Calibration Curves and QC
- Regulatory Guidance
- Overview of Validation of Methods Used for Clinical Samples
- Ligand Binding Assays and Functional Assays
- Reference Standard and Critical Reagents
- Validation Characteristics
- System Suitability and Quality Control
Rajesh K Gupta
Visionary Scientific and Compliance Consultant, Biologics Quality & Regulatory Consultants, LLC
Rajesh K. Gupta has a Ph.D. in microbiology and is the Principal Consultant at the Biologics Quality & Regulatory Consultants, LLC. He has more than 35 years' experience in the development, production, testing and regulation of biologics, working at both the regulatory agencies and the industry.
At FDA, CBER, he was a Deputy Director and the Lab Chief in the Division of Biological Standards and Quality Control, managing lot release of biological products, regulatory reviews of analytical methods in the biologics license applications (BLA), generation of reference standards and development of new methods.
In his previous jobs, he worked at the Biologics Consulting Group, Wyeth, Chiron, Massachusetts Public Health Labs and National Institutes of Health (NIH), in the USA and at National Institute of Immunology and Central Research Institute in India. His major accomplishments are in sterility assurance for biological products, adjuvants and delivery systems for vaccines, polysaccharide-protein conjugate vaccines, combination vaccines and development and validation of analytical methods. In these areas, he has published more than 100 papers in peer reviewed journals and books and has made numerous presentations at scientific and regulatory meetings.
Register Now
Online using Credit card
Get the Invitation
Pre-Register yourself and get the official Invite when venue and dates are announced for this seminar.
Call here to register +1-888-717-2436 or email at [email protected]
Other Registration Option
- Download the Order Form
- Fill this form with attendee details & payment details
- Fax it to +1-650-362-2367, or
- Email it to [email protected]
Payment Mode
ComplianceOnline (MetricStream, Inc),
6201 America Center Drive Suite 240
San Jose, CA 95002
USA
Register / Pay by Wire Transfer
Please contact us at +1-888-717-2436 to get details of wire transfer option.Terms & Conditions to Register for the Seminar/Conference/Event
Your registration for the seminar is subject to following terms and conditions. If you need any clarification before registering for this seminar please call us @ +1-888-717-2436 or email us @ [email protected]
Payment:
Payment is required 2 days before the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to MetricStream Inc. (our parent company).
Cancellations and substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 10 calendar days prior to the start date of the event will receive a refund - less a $300 administration fee. No cancellations will be accepted - nor refunds issued - within 10 calendar days before the start date of the event.
On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($300) will be transferred to any future ComplianceOnline event and a credit note will be issued.
Substitutions may be made at any time. No-shows will be charged the full amount.
We discourage onsite registrations, however if you wish to register onsite, payment to happen through credit card immediately or check to be submitted onsite. Conference material will be given on the spot if it is available after distributing to other attendees. In case it is not available, we will send the material after the conference is over.
In the event ComplianceOnline cancels the seminar, ComplianceOnline is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.
Attendance confirmation and documents to carry to the seminar venue:
After we receive the payment from the registered attendee, an electronic event pass will be sent to the email address associated with the registrant 5 working days before the seminar date. Please bring the pass to the venue of the event.
Conference photograph / video:
By registering and attending ComplianceOnline conference, you agree to have your photographs or videos taken at the conference venue and you do not have any objections to ComplianceOnline using these photos and videos for marketing, archiving or any other conference related activities. You agree to release ComplianceOnline from any kind of claims arising out of copyright or privacy violations.
- Logo on name cards
- Logo placement on the podium
- Logo on the lanyards for all speakers
- Exclusive stall at the entrance
- A full page brochure advert
- Moving banner ad on the website
- Logo on promotional email campaign
- Logo on name cards
- A half page brochure advert
- Exclusive stall at the entrance
- A quarter page brochure advert
- Moving banner ad on the website
- Logo on name cards
- Logo placement on the podium
- Logo on the lanyards for all speakers
- Exclusive stall at the entrance
- A full page brochure advert
- Moving banner ad on the website
- Logo on promotional email campaign
- Logo on name cards
- A half page brochure advert
- Exclusive stall at the entrance
- A quarter page brochure advert
If you wish to partner with us for this event please contact us: [email protected] or call us: +1-888-717-2436.
- Logo on name cards
- Logo placement on the podium
- Logo on the lanyards for all speakers
- Exclusive stall at the entrance
- A full page brochure advert
- Logo on promotional email campaign
- Logo on name cards
- A half page brochure advert
- Exclusive stall at the entrance
- A quarter page brochure advert
- Moving banner ad on the website
- Logo on name cards
- Logo placement on the podium
- Logo on the lanyards for all speakers
- Exclusive stall at the entrance
- A full page brochure advert
- Moving banner ad on the website
- Logo on promotional email campaign
- Logo on name cards
- A half page brochure advert
- Exclusive stall at the entrance
- A quarter page brochure advert
- Moving banner ad on the website
If you wish to sponsor this event please contact Cruise Webster: [email protected] or call us: (207) 576-4173
Local Attractions of San Francisco, CA
Think Escape Party Bus
San Francisco Bay Area
Board a luxurious Think Escape party bus or limo and be whisked away to San Francisco's hottest nightclubs where VIP treatment brings all party bus guests to the front of the line. Planning the perfect night on the town is easy with Think Escape's fleet of luxury buses and extended vehicles, each with different amenities for socializing and transport. Think Escape's Bay Area party bus rentals include free entry into selected exclusive nightclubs, professional hostess and chauffer, in-vehicle coolers stocked with amenities for a perfect night of partying.
Alcatraz Lunch Cruise
The Alcatraz Lunch Cruise is a luxurious way to get to see some of San Francisco’s favorite sights. A gourmet lunch buffet features options like asiago Caesar salad, bay shrimp salad, roasted chicken, garlic-herb roasted new potatoes and more. While guests enjoy lunch, they can take in views of San Francisco Bay’s flora and fauna, Angel Island and Alcatraz, and a live narration explores the history of Alcatraz. Please note that this tour doesn’t stop on Alcatraz Island.
Luxury Catamaran Sailing Cruise
A relaxing way to explore the San Francisco Bay is with the Luxury Catamaran Sailing Cruise. A drink bar and snacks are available for travelers’ enjoyment as they travel under the Golden Gate Bridge, around Alcatraz Island and even past a colony of sea lions. This is a peaceful San Francisco cruise option for families, and children under 5 ride for free.
City Kayak
City Kayak, located on San Francisco's Embarcadero close to the San Francisco Giant's ATT Park, offers a great way to experience San Francisco from Bay level, a point of view and a unique experience you'll not soon forget.
Think Escape Casino Tour
San Francisco Bay Area
San Franciscans may be familiar with Think Escape's party buses that shuttle the late-night crowds to and from various city nightclubs, but the Cache Creek Casino Escape is a little-known gem among Bay Area destinations. With personal charter service on the luxurious Fantasy Limo Bus to Cache Creek Casino and Resort, the Cache Creek Casino Escape tour is a smart choice for San Franciscans looking for a little gaming fun or planning a large group activity